featured
Efficacy and Safety of Treatment With Aldafermin in Patients With NASH and Compensated Cirrhosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Hepatology (Baltimore, Md.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis
Hepatology 2024 Mar 01;79(3)674-689, ME Rinella, HD Lieu, KV Kowdley, ZD Goodman, N Alkhouri, E Lawitz, V Ratziu, MF Abdelmalek, VW Wong, ZH Younes, AM Sheikh, D Brannan, B Freilich, F Membreno, M Sinclair, L Melchor-Khan, AJ Sanyal, L Ling, SA HarrisonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.